💊

Prescription Drugs

💊 Drugs 12,141 recalls

Superpotent Drug: Subpotent Drug. FDA analysis found this product to be Out of Specification for assay which could result in either Subpotent and/or Superpotent tablets.

Sep 5, 2017 Prescription Drugs View Details →

Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the incorrect insert for the brand name product Clolar (clofarabine) injection.

Oct 13, 2017 Prescription Drugs Nationwide View Details →

Failed dissolution specifications; all lots within expiry are being recalled due to out of specification dissolution results.

Oct 25, 2017 Prescription Drugs Nationwide View Details →